STD Testing: The Complete Guide

Educational content. For individualized guidance, consult a licensed physician. Last updated: April 23, 2026

Quick answer

A standard STD panel screens for the infections most people are actually at risk for: chlamydia, gonorrhea, syphilis, trichomoniasis, HIV, hepatitis B, hepatitis C, and herpes. Most tests use a blood draw and a urine sample, results come back in 2 to 5 business days, and an uninsured cash-pay panel typically runs between $150 and $350 depending on how many infections are included. Testing is confidential, no doctor visit is required for most panels, and results are delivered directly to the person who ordered, though certain positive results must be reported to public health departments as required by law.

A quick note before you keep reading

If you are reading this because something happened and you are nervous, take a breath. Feeling anxious is completely normal. Getting tested is one of the most grown-up, responsible things a person can do, and the fact that you are even thinking about it puts you ahead of most people. Let's walk through what you actually need to know.

One small vocabulary thing. The medical community has mostly shifted from "STD" (sexually transmitted disease) to "STI" (sexually transmitted infection), because many of these infections never actually progress to disease, and the word "disease" carries a lot of unnecessary weight. Both terms are correct. This guide uses "STD" because that is still what most people search for, but the modern clinical term is STI.

What infections does a standard STD panel test for?

The exact contents of a "full panel" vary by provider, but a comprehensive DTC (Direct-to-Consumer) panel generally covers eight infections:

• Chlamydia. The most commonly reported bacterial STI in the United States. Often has no symptoms, which is why routine screening matters. Highly treatable with a short course of antibiotics.
• Gonorrhea. Also bacterial, also frequently asymptomatic, also treatable. Gonorrhea has been developing antibiotic resistance in recent years, so catching it early matters more than it used to.
• Syphilis. Another bacterial infection. Rates have been climbing in the U.S. for over a decade. Fully curable in its early stages with penicillin.
• Trichomoniasis. A parasitic infection, often called "trich." More common than many people realize. Treated with a single-dose oral medication.
• HIV. The infection that causes AIDS if untreated. Modern antiretroviral therapy means people diagnosed with HIV today and treated promptly have near-normal life expectancy. Early detection is everything.
• Hepatitis B. A viral liver infection. Many adults clear it on their own, but some develop chronic infection. There is a vaccine, and if you are not vaccinated, your doctor will probably recommend you get it.
• Hepatitis C. Another viral liver infection, historically associated with injection drug use but also transmitted sexually in some populations. The key thing about hep C is that it is now curable with a short course of direct-acting antiviral medications.
• Herpes (HSV-1 and HSV-2). Extremely common. The CDC estimates that a majority of U.S. adults have HSV-1, and roughly one in six has HSV-2. Not curable, but can be managed effectively with antiviral medication. How much it affects day-to-day life varies a lot from person to person.

Some panels also include HPV testing, though this is more commonly done during a gynecologic exam than through a DTC panel.

How does a standard STD panel actually work?

Most comprehensive panels use two samples: a blood draw and a urine sample.

The blood draw checks for HIV, syphilis, hepatitis B, hepatitis C, and herpes. These are all infections that produce antibodies your immune system makes in response to exposure, and those antibodies are what the test detects.

The urine sample checks for chlamydia, gonorrhea, and trichomoniasis. These infections are detected using a technique called NAAT (nucleic acid amplification testing), which looks for the genetic material of the bacteria or parasite itself. NAAT testing on urine is highly accurate and much less invasive than the old-school swab method.

If a panel includes testing for throat or rectal infections, those sites require swab samples, which you collect yourself using a kit. If that sounds awkward, it is a little awkward the first time, but the instructions are clear and the whole process takes about 90 seconds.

Turnaround time from sample collection to results is typically 2 to 5 business days for most labs. Some tests return faster, some slower, depending on the lab's queue.

Full panel versus individual tests: which one makes sense?

Many individuals and healthcare providers choose a full panel. Here is the reasoning.

STIs are frequently asymptomatic. Someone can have chlamydia or gonorrhea for months without noticing, which is part of why they spread so efficiently. If you are testing at all, testing broadly catches what you would otherwise miss.

Individual tests make sense in a few specific situations:

• You have a specific known exposure and want to test for that infection only.
• You recently had a full panel come back clean and you are re-testing one infection because of a new concern.
• Cost is a hard constraint and you want to prioritize the infections most likely in your situation.

Price-wise, a full panel is almost always a better per-test value than buying tests individually. Most providers price the panel at a significant discount versus the sum of its parts.

At-home testing or in-person testing: honest tradeoffs

Both work. Here is what actually differs.

At-home test kits arrive at your door, you collect your own samples (urine, finger prick blood, or swab depending on the panel), mail them back, and get results through a secure online portal. The privacy is appealing, and for people in rural areas or with packed schedules, the convenience is real.

The tradeoff: finger-prick blood samples for some infections, particularly HIV and syphilis, are technically reliable but more prone to user error than a clean venous blood draw at a lab. If you mess up the collection, you may need to repeat it, which defeats the convenience.

In-person lab testing uses the same Quest or LabCorp locations your regular doctor would send you to. You order the panel online, receive a requisition, walk in (no appointment, typically), get your blood drawn and your urine collected in 10 minutes, and results come back through the same online portal. No physician referral is needed because the DTC platform arranges clinical oversight for you.

The tradeoff: you have to physically go to the lab. For most people in most cities, there is a Quest or LabCorp within 15 minutes, so this is a minor lift.

A note on choosing between the two: in-person lab testing can reduce the risk of sample collection errors compared to at-home kits, though both are viable options depending on access and preferences. For people with limited lab access, or those who prefer not to leave the house for this specifically, at-home is a completely legitimate choice. The underlying testing is the same. What matters most is that testing happens at all.

What does STD testing cost, and why does it vary so much?

Without insurance, a comprehensive DTC panel typically ranges from $150 to $350. The range reflects differences in how many infections are included, whether herpes testing is bundled (herpes testing is expensive and some panels exclude it by default), and what the provider's markup looks like.

A quick note about insurance. Yes, most health insurance plans cover STD testing, sometimes at 100% as a preventive service under the Affordable Care Act. But a lot of people choose to pay out of pocket anyway, for one specific reason: when insurance processes a claim, the billing code, the diagnosis, and the facility become part of the insurance record. For most people this is completely fine. For others (people on a parent's plan, people in specific career fields, people in the middle of a divorce, people who just value privacy), paying cash keeps the whole thing off the insurance record entirely.

This is not paranoia. It is a legitimate reason people choose DTC testing, and it is why the category exists. There is nothing weird about wanting to keep a medical record private, and no one should make you feel otherwise.

What happens when results come back?

Results arrive through a secure online portal, not email, not text, not snail mail. You log in, you see your results, and you decide what to do next.

If everything is negative: that is the result most people get. The infections screened for are common in the population, but any given individual's odds of being positive for any single infection, on any single test, are relatively low. Negative results mean the test didn't detect the infection at a level above the lab's threshold. Re-test at appropriate intervals based on your risk profile (more on that below).

If something comes back positive: this is not the disaster it feels like in the first 30 seconds. Every infection on a standard panel is either fully curable or, in the case of viral infections (HIV, herpes, hepatitis B), effectively managed with modern medication. A positive result means it is time to consult a healthcare provider about treatment or management options. It does not mean your life is over. For many people, it does not even mean a significant change to daily life once treatment or medication is underway.

Most DTC platforms include a post-test consultation with a physician at no extra charge if you test positive. They will review the result, explain the treatment options, answer your questions, and in many cases write the prescription or coordinate the next steps.

If you test positive for something that is bacterial (chlamydia, gonorrhea, syphilis, trichomoniasis), you will be advised to notify recent partners so they can get tested and treated. That conversation is uncomfortable. It is also the adult thing to do, and most people on the receiving end handle it better than you would expect. Many platforms offer anonymous partner notification services if you prefer.

Privacy and confidentiality: how it actually works

Confidentiality in DTC testing is not a marketing claim, it is a regulatory requirement. Here is what that means in practice.

The lab (Quest or LabCorp) processes your sample under the same HIPAA protections that apply to any other medical test. The DTC platform that brokered your order has limited access: they can confirm a result exists and facilitate your access to it, but they are not distributing your results to anyone.

Your results are kept confidential from your insurance company (when you pay cash), your employer, and your primary care doctor (unless you choose to share them). Certain positive results (HIV, syphilis, and a handful of others) are reportable to public health authorities for epidemiological tracking, but those reports do not include your name, address, or contact information unless you specifically consent to be contacted for partner notification support.

The one thing worth knowing: if you use the same email address and name to order a DTC test that you use for your regular healthcare, there is always some small risk of crossover in digital records. People who are particularly privacy-sensitive sometimes use a dedicated email for this purpose. For most people this is overkill. For some people it is a comfort.

How often should a person get tested?

The CDC's general guidance:

• Sexually active adults under 25: annual screening for chlamydia and gonorrhea at minimum.
• Sexually active adults 25 and older: screening based on risk factors (new partners, multiple partners, partner with an STI).
• Men who have sex with men: more frequent screening, often every 3 to 6 months, with additional site-specific testing (throat and rectal).
• Pregnant individuals: early-pregnancy screening for HIV, syphilis, and hepatitis B is standard, with additional screening based on risk.
• After a new partner or a partner change: general guidelines suggest testing at 2 to 4 weeks for bacterial infections, and at 3 months for HIV and syphilis (this is the window period during which antibody-based tests become reliable).
• If a condom breaks or a known exposure occurs: follow the window-period guidance above, and talk to a physician about whether post-exposure prophylaxis for HIV is appropriate in your situation.

These are guidelines, not rules. If testing more often makes you feel more in control of your health, that is a completely valid reason to test more often.

The short version

Getting tested is responsible, confidential, and almost always less of a big deal than people build it up to be in their heads. A comprehensive panel screens broadly for infections that are often asymptomatic, in-person and at-home are both legitimate options, results stay confidential (with limited public health reporting exceptions noted earlier), and positive results are treatable. If you are thinking about it, that is a good enough reason to look into it.

Take care of yourself.